Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals Limited has informed the stock exchanges that its trading window will be closed starting July 01, 2025, in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The window will remain shut for designated persons and their immediate relatives until 48 hours after the company declares its unaudited financial results for the first quarter ending June 30, 2025. This is a standard compliance measure taken by listed companies ahead of quarterly earnings announcements to prevent insider trading. The company's Q1 FY26 results are expected to be announced in the coming weeks, after which the trading window will reopen.
This is a routine regulatory filing with no direct impact on shareholders or stock price. It simply means company insiders cannot trade shares until Q1 FY26 results are declared, which is standard practice ahead of earnings announcements.